Li Yao, Tong Nanwei
Department of Endocrinology, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China.
Department of Endocrinology, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China
J Renin Angiotensin Aldosterone Syst. 2015 Dec;16(4):787-92. doi: 10.1177/1470320314539828. Epub 2014 Aug 20.
Several molecular epidemiological studies have been conducted to examine the association between angiotensin-converting enzyme (ACE) I/D polymorphism and diabetic peripheral neuropathy (DPN) risk. However, the conclusions remained controversial. We therefore performed this meta-analysis.
PubMed and EMBASE were searched to identify case-control studies investigating the associations of ACE I/D polymorphism with risk of DPN. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of association between ACE I/D polymorphism and risk of DPN.
A total of seven case-control studies including 1316 cases and 1617 controls were included. ACE I/D polymorphism was associated with a significantly increased risk of DPN (OR=1.46, 95%CI 1.11-1.92, p=0.006, I(2)=48%). This result remained statistically significant when the adjusted ORs were combined (OR=1.84, 95%CI 1.14-2.99, p=0.01, I(2)=53%). In the subgroup of ethnicity, a significantly elevated risk was observed in Caucasians (OR=1.32, 95%CI 1.10-1.59, p=0.003, I(2)=43%).
Our meta-analysis confirmed that ACE I/D polymorphism was associated with the risk of DPN.
已经开展了多项分子流行病学研究,以探讨血管紧张素转换酶(ACE)I/D多态性与糖尿病周围神经病变(DPN)风险之间的关联。然而,结论仍存在争议。因此,我们进行了这项荟萃分析。
检索PubMed和EMBASE,以确定调查ACE I/D多态性与DPN风险之间关联的病例对照研究。采用比值比(OR)及其95%置信区间(CI)来评估ACE I/D多态性与DPN风险之间关联的强度。
共纳入7项病例对照研究,包括1316例病例和1617例对照。ACE I/D多态性与DPN风险显著增加相关(OR=1.46,95%CI 1.11-1.92,p=0.006,I²=48%)。当合并调整后的OR时,该结果仍具有统计学意义(OR=1.84,95%CI 1.14-2.99,p=0.01,I²=53%)。在种族亚组中,白种人的风险显著升高(OR=1.32,95%CI 1.10-1.59,p=0.003,I²=43%)。
我们的荟萃分析证实,ACE I/D多态性与DPN风险相关。